We have to raise the issue of the length of time it takes for some products to be registered. For example, in the document we received which compared competitivity, we see that European veterinary drugs are registered much more quickly. Generally, it took less than two years to do a risk management study for a group of four archetypal drugs that were reviewed. Whereas here, it takes between five and eight and a half years to do the same work on the same four products. Comparison shows that the registration process does not work very quickly here.
Why is that? Is there a staff shortage, or is it simply that we require more in-depth studies, for safety reasons?